Results 21 to 30 of about 292,965 (296)

LSD and AMAZE: the mass-metallicity relation at z>3 [PDF]

open access: yes, 2008
We present the first results on galaxy metallicity evolution at z>3 from two projects, LSD (Lyman-break galaxies Stellar populations and Dynamics) and AMAZE (Assessing the Mass Abundance redshift Evolution).
Edmunds   +7 more
core   +1 more source

Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography–Tandem Mass Spectrometry Methods

open access: yesSeparations, 2023
Lysergic acid diethylamide (LSD) is a powerful hallucinogen. Its detection is limited by its low dosage; moreover, LSD is rapidly metabolized into 2-oxo-3-hydroxy-LSD (O-H-LSD).
Alexandra Dimitrova   +5 more
doaj   +1 more source

EASTERN MYSTICISM AND TIMOTHY LEARY: HUMAN BEYOND THE CONVENTIONAL REALITY

open access: yesAntropologìčnì Vimìri Fìlosofsʹkih Doslìdžen', 2017
Introduction. The complex multifaceted essence of human as a biological, psychological, social being has attracted the attention of researchers and has caused hot debates during centuries.
T. V. Danylova
doaj   +1 more source

Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment

open access: yesDiagnostics, 2020
Intraocular lesions have been infrequently reported in patients with Gaucher disease type 3 (GD3). We previously reported siblings with GD3 who responded well to the combination of enzyme replacement therapy (ERT) and substrate reduction therapy (SRT ...
Aizeddin Mhanni   +8 more
doaj   +1 more source

Validation of the 5-domain Niemann-Pick type C Clinical Severity Scale

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Niemann-Pick disease type C (NPC) is an ultra-rare, progressive, genetic disease leading to impaired lysosomal function and neurodegeneration causing serious morbidity and shortened life expectancy.
Marc C. Patterson   +8 more
doaj   +1 more source

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders

open access: yesCell Reports, 2023
Summary: Hallucinations limit widespread therapeutic use of psychedelics as rapidly acting antidepressants. Here we profiled the non-hallucinogenic lysergic acid diethylamide (LSD) analog 2-bromo-LSD (2-Br-LSD) at more than 33 aminergic G protein-coupled
Vern Lewis   +18 more
doaj   +1 more source

A new method of measuring center-of-mass velocities of radially pulsating stars from high-resolution spectroscopy [PDF]

open access: yes, 2017
We present a radial velocity analysis of 20 solar neighborhood RR Lyrae and 3 Population II Cepheids variables. We obtained high-resolution, moderate-to-high signal-to-noise ratio spectra for most stars and obtained spectra were covering different ...
Britavskiy, N. E.   +4 more
core   +2 more sources

Assessment of Humoral Immune Response in Pre- and Post-Vaccinated Cattle Against Lumpy Skin Disease

open access: yesVeterinary Medicine: Research and Reports, 2023
Nebyou Moje,1 Fufa Dawo Bari,1 Beksisa Urge,2 Ejigayehu Demissie2 1College of Veterinary Medicine and Agriculture, Addis Ababa University, Bishoftu, Ethiopia; 2Holeta and Debre Zeit Agricultural Research Centers, EIAR, Oromia, EthiopiaCorrespondence ...
Moje N, Bari FD, Urge B, Demissie E
doaj  

Least squares deconvolution of the stellar intensity and polarization spectra

open access: yes, 2010
Least squares deconvolution (LSD) is a powerful method of extracting high-precision average line profiles from the stellar intensity and polarization spectra.
Kochukhov, O.   +2 more
core   +1 more source

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects [PDF]

open access: yes, 2017
Lysergic acid diethylamide (LSD) induces profound changes in various mental domains, including perception, self-awareness and emotions. We used functional magnetic resonance imaging (fMRI) to investigate the acute effects of LSD on the neural substrate ...
Borgwardt, S.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy